![](/img/cover-not-exists.png)
Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone
Bianchini, D., Lorente, D., Rodriguez-Vida, A., Omlin, A., Pezaro, C., Ferraldeschi, R., Zivi, A., Attard, G., Chowdhury, S., de Bono, J.S.Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2013.08.020
Date:
January, 2014
File:
PDF, 469 KB
english, 2014